Immediate Impact
5 by Nobel laureates 13 from Science/Nature 59 standout
Citing Papers
Evaluating eligibility criteria of oncology trials using real-world data and AI
2021 StandoutNature
Applications of bioluminescence in biotechnology and beyond
2021 Standout
Works of Paul Sargeant being referenced
Desktop software to identify patients eligible for recruitment intoa clinical trial: using SARMA to recruit to the ROAD feasibilitytrial
2010
The tyrosine kinase inhibitors methyl 2,5‐dihydroxycinnamate and genistein reduce thrombin‐evoked tyrosine phosphorylation and Ca2+ entry in human platelets
1993
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Paul Sargeant | 287 | 132 | 22 | 91 | 9 | 524 | |
| Nidhal Ben Amor | 165 | 152 | 36 | 57 | 22 | 523 | |
| Li‐Chieh Ching | 214 | 60 | 190 | 72 | 9 | 559 | |
| Louise A. Rafty | 299 | 56 | 18 | 15 | 10 | 499 | |
| Toyohiko Tohmatsu | 318 | 12 | 34 | 52 | 15 | 505 | |
| Juan E. Camacho Londoño | 297 | 296 | 43 | 26 | 14 | 548 | |
| Sheila Hassock | 232 | 229 | 14 | 80 | 10 | 476 | |
| Véronique Juvin | 384 | 240 | 67 | 11 | 9 | 643 | |
| Isabelle Arnould | 314 | 31 | 340 | 16 | 10 | 626 | |
| Gavin Landesberg | 135 | 39 | 32 | 46 | 11 | 470 | |
| Lai‐Ming Yung | 181 | 49 | 88 | 29 | 15 | 617 |
All Works
Loading papers...